Biểu đồ giá cổ phiếu DMPHF
DMPHF Dự đoán giá cổ phiếu
Dermapharm Holding SE
$47.69
0%
$0
Tính đến ngày hôm nay:Aug 07, 10:09:04 GMT-4
Quay lại
Dermapharm Holding SE (DMPHF) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$47.69
Giá mở cửa
$47.69
Phạm vi ngày
$47.69 - $47.69
Phạm vi 52 tuần
$39.56 - $53
Khối lượng
100
Khối lượng trung bình
3
Tỷ suất cổ tức
--
EPS (TTM)
3.09
Vốn hóa thị trường
$2.3B
Dermapharm Hldg SE là gì?
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The firm operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. The company holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The firm offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. The company is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
